Clinical trial
Xarelto® for Real Life Anticoagulation in Pulmonary Embolism (PE) in China
NCT03410706 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Xarelto® for Real Life Anticoagulation in Pulmonary Embolism (PE) in China
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 1, 2018
- Completion date
- December 24, 2021
- Enrollment
- 288 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.